Hydrogenology
Source-linked study record

Conflicting findings on the effectiveness of hydrogen therapy for ameliorating vascular leakage in a 5-day post hypoxic-ischemic survival piglet model

Htun Y, Nakamura S, Nakao Y, Mitsuie T, Ohta K, Arioka M, Yokota T, Inoue E, Inoue K, Tsuchiya T, Koyano K, Konishi Y, Miki T, Ueno M, Kusaka T. · Scientific Reports. 2023;13:10486.

PreclinicalInhaled H₂Published 2023Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Newborn piglets exposed to a controlled hypoxic-ischemic insult and followed for five days.

Intervention and dose

After resuscitation, H₂ ventilation was given for 24 hours, either with normothermia or with whole-body therapeutic hypothermia at 33.5±0.5°C. · A cylinder containing 3.8% H₂/96.2% N₂ was blended with 100% O₂. Delivered H₂ varied from 2.1% to 2.7% as each piglet's FiO₂ was adjusted from 0.21 to 0.40.

Duration

Twenty-four hours of H₂ ventilation; neurological recovery was observed for five days and brains were assessed on day five.

Reported result

The prespecified albumin-leakage outcome was numerically lower with H₂ alone but did not differ significantly among the four groups. Neurological and physiological measures produced mixed secondary findings; the article therefore explicitly reports conflicting rather than uniformly positive evidence.

Main limitation

Preclinical piglet model, only 26 analyzed animals, seven post-randomization exclusions based on insult duration, four small groups and a histological surrogate primary outcome. H₂ concentration varied with oxygen requirement and total gas flow was not reported. Japanese JSPS KAKENHI grants funded the study; sponsors reportedly had no study role and the authors declared no competing interests.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Randomized four-group newborn-piglet hypoxic-ischemic survival experiment

Research topic

Other neurological conditions

Administration form

Inhaled H₂

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Newborn piglets exposed to a controlled hypoxic-ischemic insult and followed for five days.

Sample

33 piglets were randomized; 26 met the prespecified insult-duration analysis range: normothermia n=7, H₂ n=7, therapeutic hypothermia n=6 and H₂ plus hypothermia n=6.

Duration

Twenty-four hours of H₂ ventilation; neurological recovery was observed for five days and brains were assessed on day five.

Intervention

After resuscitation, H₂ ventilation was given for 24 hours, either with normothermia or with whole-body therapeutic hypothermia at 33.5±0.5°C.

Hydrogen form

H₂ alone diluted in nitrogen and clinical oxygen — not Brown's gas.

Dose or H₂ specification

A cylinder containing 3.8% H₂/96.2% N₂ was blended with 100% O₂. Delivered H₂ varied from 2.1% to 2.7% as each piglet's FiO₂ was adjusted from 0.21 to 0.40.

H₂ flow

Not reported — the article gives H₂ concentration and ventilator duration but not total ventilation flow, so mL/min cannot be calculated.

O₂ delivered with H₂

FiO₂ was adjusted from 21% to 40%; O₂ flow in mL/min was not reported.

Comparator

Normothermia without H₂ and therapeutic hypothermia without H₂, creating four randomized groups.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Albumin immunohistochemistry as a marker of cerebral vascular leakage, neurological scores, physiological and blood-gas variables, cerebral blood volume and cerebral hemoglobin oxygenation.

Reported result

The prespecified albumin-leakage outcome was numerically lower with H₂ alone but did not differ significantly among the four groups. Neurological and physiological measures produced mixed secondary findings; the article therefore explicitly reports conflicting rather than uniformly positive evidence.

Extraction completeness

The complete open-access publisher article, exclusions, group sizes, gas preparation, positive and null outcomes, funding, sponsor role and conflict statement were checked.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Preclinical piglet model, only 26 analyzed animals, seven post-randomization exclusions based on insult duration, four small groups and a histological surrogate primary outcome. H₂ concentration varied with oxygen requirement and total gas flow was not reported. Japanese JSPS KAKENHI grants funded the study; sponsors reportedly had no study role and the authors declared no competing interests.

Applies directly to

Newborn-piglet hypoxic-ischemic encephalopathy model; the null vascular-leakage result does not establish benefit in human newborns.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 37380745 · DOI: 10.1038/s41598-023-37577-0

Publisher access

Open-access Scientific Reports article and PubMed Central copy.

Extraction basis

Scientific Reports publisher article, PubMed Central copy and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.